Table 1.
Frequencies of baseline clinical parameters of the study groups
| Normal N (%) | DM N (%) | CAD N (%) | DM+CAD (0-5y) N (%) | DM+CAD (5-10y) N (%) | |
|---|---|---|---|---|---|
|
Age |
|
|
|
|
|
| >
45
|
47 (38.8) |
18 (18) |
13 (10.6) |
6 (5.9) |
3 (2.8) |
| <
45
|
74 (61.1) |
83 (83) |
109 (85.3) |
97 (95.1) |
106 (97.2) |
|
Gender |
|
|
|
|
|
|
Male
|
66 (54.5) |
49 (49) |
102 (83.6) |
83 (81.4) |
78 (71.6) |
|
Female
|
55 (48.4) |
52 (52) |
20 (16.3) |
20 (19.6) |
3 (28.4) |
|
FBS (mg/dL) |
|
|
|
|
|
|
70
-
110
|
89 (73.5) |
26 (26) |
43 (35.2) |
25 (24.5) |
21 (19.3) |
| >
110
|
32 (26.4) |
75 (75) |
79 (64.7) |
78 (76.5) |
88 (80.7) |
|
HbA1C (%) |
|
|
|
|
|
| <
5.7
|
88 (72.7) |
4 (4) |
50 (40.9) |
1 (1) |
3 (2.8) |
|
5.7
-
6.4
|
28 (23.1) |
6 (6) |
40 (32.70 |
19 (18.6) |
5 (4.6) |
| >
6.5
|
5 (4.1) |
91 (91) |
32 (26.2) |
83 (81.4) |
101 (92.7) |
|
Total cholesterol (mg/dL) |
|
|
|
|
|
| <
200
|
64 (52.8) |
58 (58) |
90 (73.7) |
78 (76.5) |
80 (73.4) |
|
200
-
240
|
37 (30.5) |
36 (36) |
15 (72.2) |
12 (11.8) |
13 (11.9) |
| >
240
|
20 (16.5) |
7 (7) |
17 ( (13.9) |
13 (12.7) |
16 (14.7) |
|
LDL (mg/dL) |
|
|
|
|
|
| <
100
|
91 (75.2) |
33 (33) |
78 (63.9) |
68 (66.7) |
64 (58.7) |
| >
100
|
30 (24.7) |
68 (68) |
44 (36.1) |
35 (34.3) |
45 (41.3) |
|
HDL (mg/dL) |
|
|
|
|
|
| <
60
|
113 (43.3) |
90 (90) |
117 (95.9) |
100 (98) |
104 (95.4) |
| >
60
|
8 (6.6) |
11 (11) |
5 (4.1) |
3 (2.9) |
5 (4.6) |
|
Triglycerides (mg/dL) |
|
|
|
|
|
| <
150
|
113 (43.3) |
90 (90) |
78 (63.9) |
64 (62.7) |
77 (70.6) |
| > 150 | 8 (6.6) | 11 (11) | 44 (36.1) | 39 (38.2) | 32 (29.4) |